Open Beta
TREN
MetriLume
TREN

US marketsRCEL

SEC-sourced researchBeta

RCEL

AVITA Medical, Inc.

Company comparison ↗

Data passport

CIK
0001762303
Exchange
Nasdaq
Business activity
Surgical & Medical Instruments & Apparatus · SIC 3841
Financial inputs
6/6
Filing date
Aug 25, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 64,251,000.0000 USD; December 2025: 71,610,000.0000 USD71.6M USD0 USD0December 2024December 2025
RCEL · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202464,251,000.0000Feb 12, 2026
December 202571,610,000.0000Feb 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202571,610,000.0000-48,587,000.0000-31,195,000.000056,392,000.000073,042,000.0000Feb 12, 2026
December 202464,251,000.0000-61,845,000.0000-48,939,000.000079,711,000.000074,968,000.0000Feb 12, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

32/100
Profitability0
Growth61
Balance sheet0
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$71.61MJan 1, 2025 – Dec 31, 2025Feb 12, 202610-K
Previous period revenueRevenues$64.25MJan 1, 2024 – Dec 31, 2024Feb 12, 202610-K
Net incomeNetIncomeLoss-$48.59MJan 1, 2025 – Dec 31, 2025Feb 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$31.2MJan 1, 2025 – Dec 31, 2025Feb 12, 202610-K
Total assetsAssets$56.39MDec 31, 2025Feb 12, 202610-K
Total liabilitiesLiabilities$73.04MDec 31, 2025Feb 12, 202610-K

New filings

Explore methodology ↗